APR-246 induces early cell death by ferroptosis in acute myeloid leukemia

Bibliographic Details
Title: APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
Authors: Rudy Birsen, Clement Larrue, Justine Decroocq, Natacha Johnson, Nathan Guiraud, Mathilde Gotanegre, Lilia Cantero-Aguilar, Eric Grignano, Tony Huynh, Michaela Fontenay, Olivier Kosmider, Patrick Mayeux, Nicolas Chapuis, Jean Emmanuel Sarry, Jerome Tamburini, Didier Bouscary
Source: Haematologica, Vol 107, Iss 2 (2021)
Publisher Information: Ferrata Storti Foundation, 2021.
Publication Year: 2021
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
More Details: APR-246 is a promising new therapeutic agent that targets p53 mutated proteins in myelodysplastic syndromes and in acute myeloid leukemia (AML). APR-246 reactivates the transcriptional activity of p53 mutants by facilitating their binding to DNA target sites. Recent studies in solid cancers have found that APR-246 can also induce p53-independent cell death. In this study, we demonstrate that AML cell death occurring early after APR-246 exposure is suppressed by iron chelators, lipophilic antioxidants and inhibitors of lipid peroxidation, and correlates with the accumulation of markers of lipid peroxidation, thus fulfilling the definition of ferroptosis, a recently described cell death process. The capacity of AML cells to detoxify lipid peroxides by increasing their cystine uptake to maintain major antioxidant molecule glutathione biosynthesis after exposure to APR-246 may be a key determinant of sensitivity to this compound. The association of APR-246 with induction of ferroptosis (either by pharmacological compounds, or genetic inactivation of SLC7A11 or GPX4) had a synergistic effect on the promotion of cell death, both in vivo and ex vivo.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 0390-6078
1592-8721
Relation: https://haematologica.org/article/view/10139; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721
DOI: 10.3324/haematol.2020.259531
Access URL: https://doaj.org/article/450db381926d46e993daececdc3996e8
Accession Number: edsdoj.450db381926d46e993daececdc3996e8
Database: Directory of Open Access Journals
More Details
ISSN:03906078
15928721
DOI:10.3324/haematol.2020.259531
Published in:Haematologica
Language:English